GSK R&D Expenses

GSK plc American Depositary Shares (Each representing two Ordinary Shares) · R&D Expenses

GSK logo

GSK R&D Expenses

Latest reported£3.47B GBP
GSK Quarterly R&D Expenses · GBP (£0.00 → £3.47B)
High-resolution chart · PNG

GSK r&d expenses history

Quarterly · GBP. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) R&D Expenses — Quarterly (GBP)
Period endingR&D Expenses (GBP)
3,466,000,000
1,692,000,000
2,350,000,000
1,689,000,000
2,024,000,000
1,462,000,000
2,031,000,000
1,459,000,000
1,477,000,000
1,434,000,000
2,047,000,000
1,575,000,000
1,341,000,000
1,260,000,000
1,797,000,000
1,346,000,000
1,242,000,000
1,103,000,000
1,448,000,000
1,416,000,000
1,167,000,000
1,118,000,000
1,470,000,000
1,140,000,000
1,301,000,000
1,187,000,000
1,243,000,000
1,206,000,000
1,113,000,000
1,006,000,000
1,076,000,000
988,000,000
925,000,000
904,000,000
1,209,000,000
1,047,000,000
1,260,000,000
960,000,000
1,003,000,000
922,000,000
888,000,000
815,000,000
1,054,000,000
827,000,000
812,000,000
867,000,000
979,000,000
803,000,000
809,000,000
859,000,000
1,070,000,000
900,000,000
1,049,000,000
904,000,000
1,141,000,000
937,000,000
924,000,000
974,000,000
1,095,000,000
984,000,000
1,015,000,000
915,000,000
1,097,000,000
1,004,000,000
1,196,000,000
1,160,000,000
1,127,000,000
882,000,000
973,000,000
1,124,000,000
1,212,000,000
869,000,000
820,000,000
780,000,000
956,310,500
768,898,130
789,000,000
726,000,000
978,986,110
871,000,000
853,440,860
751,969,380
967,358,000
803,000,000
701,149,000
663,000,000
786,762,480
695,996,340
696,000,000
659,000,000
818,120,000
681,000,000
647,567,740
640,432,260
905,000,000
706,000,000
623,000,000
666,000,000
652,903,830
657,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.